Open access
Sep 2026
Safety of Sodium/Glucose Cotransporter 2 Inhibitors in Patients With Type 2 Diabetes and CKD.
RATIONALE & OBJECTIVE Patients with chronic kidney disease (CKD) are often underrepresented in clinical trials evaluating the safety profile of newer medication classes for type 2 diabetes (T2D). Given the high burden of comorbidities and polypharmacy in this population, further safety research is needed. This study ai...
J. Ortega-Montiel, Wajd Alkabbani, Georg Hahn et al.
· American Journal of Kidney D... · 0 citations